Table of Contents Table of Contents
Previous Page  20 / 154 Next Page
Show Menu
Previous Page 20 / 154 Next Page
Page Background

Speaker’s Biographies

Florian Scotté

European Hospital Georges Pompidou, Paris, France

Florian Scotté is MD-PhD and medical oncologist at the European Hospital Georges Pompidou (Paris, France), and head

of the SCUPP (Supportive Care in Cancer Unit Pompidou Paris).

He is member of the ESMO, MASCC (Multinational Association for Supportive Care in Cancer), the ASCO, CKIN

5cancer and the Kidney International Network) and is General Secretary of the AFSOS (French Speaking Association

for Supportive Care in Cancer).

Teaching at several universities, and Coordinator of the inter-university diploma of supportive care, he is involved in

training both medical and para-medical.

He is also the coordinator and co-investigator of numerous studies especially in supportive care: GTP 001, the effectiveness

of a glove refrigerant preventing onycholysis, AESCO 001, the effectiveness of a liner refrigerant prevention of skin and

nail toxicities, AESCO 002, the effectiveness of a cooling jacket on the hands and feet in the prevention of hand foot

syndrome, but also analysis of the requirements of recombinant erythropoietin in oncology. He recently published data

on supportive care status in France and new organisation in ambulatory chemotherapy administration.

He also serves on the editorial board of Elsevier Quality of Life Website and « La Lettre du Cancérologue » and coordinate

« news on line » programs during international meetings on


Speaker Abstract(s): S53, S54

Ponnandai Somasundar

Boston University, Surgery, Providence, Rhode Island, USA

Ponnandai Somasundar MD is a surgical oncologist with interest in GI cancers with an expertise in minimally invasive

surgery. He is an Associate Professor of Surgery in Boston University and Associate Chief of Surgical Oncology in Roger

Williams Medical Center. He is also the Director of Geriatric Oncology Program with a special interest in taking care of

the elderly with cancer. He runs the geriatric oncology program in his institution. He is well published in multiple peer

reviewed journals. He is a member of multiple national and international surgical organizations and actively participates

in them.

Speaker Abstract(s): S55

Pierre Soubeyran

Université de Bordeaux, Medical Oncology, Bordeaux, France

Pierre Soubeyran, M.D., Ph.D., is a Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center in Bordeaux,

and Professor of Medical Oncology at the University of Bordeaux. He is highly involved in the development of Geriatric

Oncology at both the clinical (co-coordinator of the Coordination Unit of Geriatric Oncology of Aquitaine) and research level

(President of the Scientific Council of the French Society of Geriatric Oncology (SoFOG) and Coordinator of the French

Geriatric Oncology Cooperative Group DIALOG). He is also involved in cancer research as Director of Research of Institut

Bergonié comprehensive cancer center in Bordeaux, Director of the U1218 INSERM Cancer research unit and Director of

the SIRIC, Center for Integrated Cancer Research of Bordeaux, named BRIO (Bordeaux Recherche Intégrée Oncologie).

He earned his Medical Degree from the University of Nantes in France and trained in Medical Oncology at the Institut

Bergonié and University of Bordeaux. He completed a fellowship at the MD Anderson Cancer Center in Houston and later

obtained his Ph.D. at the University of Bordeaux in the field of minimal residual disease in follicular lymphoma. An active

researcher, Prof. Pierre Soubeyran’s clinical interests include clinical and biological research on lymphoma and geriatric

oncology. He is leading trials focused on these topics as part of the French LYSA lymphoma Research Group and the

French Geriatric Oncology Cooperative Group DIALOG. He is a member of ESMO, ASCO, ASH, SoFOG and SIOG. He

has authored and co-authored numerous articles, book chapters and monographs on various aspects of cancer treatment.

Speaker Abstract(s): S57, S58, S59

Reinhard Stauder

Medical University Innsbruck


Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria

Reinhard Stauder received his Doctoral Degree in Medicine in 1981 from the University of Innsbruck and in 2006 received

a Master’s Degree in Health Sciences from the University of Health Sciences, Medical Informatics and Technology, Hall

in Tirol, Austria. From 1994–1996, he was Scientific Member at the Basel Institute for Immunology, Basel, Switzerland.

RS is a specialist in Internal Medicine, a Certified Specialist in Hematology and Oncology and Associate Professor

of Medicine at Innsbruck Medical University, Austria. His main clinical and scientific focus lies in Myelodysplastic

Syndromes (MDS), in geriatric oncology and in anemia in the elderly. His main goal is the development of individualized

treatment algorithms in elderly cancer patients.

At present RS is responsible for the geriatric oncology and MDS program of the Department of Internal Medicine V

(Haematology and Oncology), Innsbruck Medical University. RS is a member of the European Leukemia Net (ELN) and

is representative of Austria in the European LeukemiaNet MDS registry (EU-MDS). RS is a member of the board of

the Austrian Society for Haematology and Oncology (OEGHO) as well as vice-chairman of the Austrian MDS-Plattform

and chairman of the Geriatric Oncology Group of the OEGHO. RS is the National Representative for Austria in the